Cited by 610Antifungal resistance and susceptibilityFungal Infections and StudiesYeasts and Rust Fungi Studies

The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.

Epidemiology and risk factors for invasive candidiasis

Open access

Yapar, Nur·2014·Therapeutics and Clinical Risk Management

Open this paper in CoChat — free account Open PDF

Abstract

The number of immunosuppressive patients has increased significantly in recent years. These patients are at risk for opportunistic infections, especially fungal infections. Candidiasis is one of the most frequent fungal infections determined in these immunosuppressive patients and its epidemiology has changed over the last two decades. Recently, new antifungal agents and new therapy strategies such as antifungal prophylaxis, secondary prophylaxis, and preemptive therapy have come into use. These changes resulted in the alteration of Candida species causing invasive infections. The incidence of Candida albicans was decreased in many countries, especially among patients with immunosuppressive disorders, while the incidence of species other than C. albicans was increased. In this review, incidence, risk factors, and species distribution of invasive candidiasis are discussed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2147/tcrm.s40160

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Nationwide Sentinel Surveillance of Bloodstream Candida Infections in 40 Tertiary Care Hospitals in Spain
Cisterna, R., Ezpeleta, G., Tellería, O., Guinea, J., Regueiro, B. J., Garcia-Rodríguez, J., & Esperalba, J. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00920-10 · Cited by 72
Retracted
Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010
Sievert, D. M., Ricks, P., Edwards, J. R., Schneider, A. K., Patel, J. B., Srinivasan, A., Kallen, A. J., Limbago, B. M., Fridkin, S. K., & National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/668770 · Cited by 1,593
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140
Untitled work
(2006) · PubMed · Cited by 906
Candida Colonization and Subsequent Infections in Critically III Surgical Patients
Pittet, D., Monod, M., Suter, P. M., Frenk, E., & Auckenthaler, R. (1994) · Annals of Surgery · doi:10.1097/00000658-199412000-00008 · Cited by 798
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion
Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ellis, D., Tullio, V., Rodloff, A., Fu, W., & Ling, T. A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-09 · Cited by 718
Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)
Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514731 · Cited by 601

Show all 70 references

Research works printed but not linked: 2

[7]Lewis RE Overview of the changing epidemiology of candidemia Curr Med Res Opin 2009 25 7 1732 1740 19519284
[48]Yapar N Akan M Avkan-Oguz V Ergon M Hancer M Doluca-Yucesoy M Risk factors and the incidence of candidemia in the intensive care unit: A 5-year cross-sectional study Proceedings of Twentieth European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) April 10–14, 2010 Vienna, Austria Wiley-Blackwell 2010

Sorted by citations

Candida albicans—The Virulence Factors and Clinical Manifestations of Infection
Talapko, J., Juzbašić, M., Matijević, T., Pustijanac, E., Bekić, S., Kotris, I., & Škrlec, I. (2021) · Journal of Fungi · doi:10.3390/jof7020079 · Cited by 794
“Candida albicans is the most typical cause of candidiasis, although many Candida species other than albicans have been isolated in recent years [105,145].”
Background
Candida Biofilms: Threats, Challenges, and Promising Strategies
Cavalheiro, M., & Teixeira, M. C. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00028 · Cited by 690
Mammalian lipoxygenases and their biological relevance
Kühn, H., Banthiya, S., & van Leyen, K. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.10.002 · Cited by 644
Antifungal resistance: current trends and future strategies to combat
Wiederhold, N. P. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s124918 · Cited by 492
The Still Underestimated Problem of Fungal Diseases Worldwide
Almeida, F. B. D. R., Rodrigues, M. L., & Coelho, C. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00214 · Cited by 452
Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis
Hargrove, T. Y., Friggeri, L., Wawrzak, Z., Qi, A., Hoekstra, W. J., Schotzinger, R. J., York, J. D., Guengerich, F. P., & Lepesheva, G. I. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.778308 · Cited by 444
The impact of the Fungus-Host-Microbiota interplay uponCandida albicansinfections: current knowledge and new perspectives
d’Enfert, C., Kaune, A.-K., Alaban, L. R., Chakraborty, S., Cole, N. L., Delavy, M., Kosmala, D., Marsaux, B., Fróis-Martins, R., Morelli, M., et al. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa060 · Cited by 377
Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis
Koehler, P., Stecher, M., Cornely, O. A., Koehler, D., Vehreschild, M. J. G. T., Bohlius, J., Wisplinghoff, H., & Vehreschild, J. J. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.04.024 · Cited by 336
Effect of silver nanoparticles on Candida albicans biofilms: an ultrastructural study
Lara, H. H., Romero-Urbina, D. G., Pierce, C., Lopez-Ribot, J. L., Arellano-Jiménez, M. J., & Jose-Yacaman, M. (2015) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0147-8 · Cited by 323
Investigating Colonization of the Healthy Adult Gastrointestinal Tract by Fungi
Auchtung, T. A., Fofanova, T. Y., Stewart, C. J., Nash, A. K., Wong, M. C., Gesell, J. R., Auchtung, J. M., Ajami, N. J., & Petrosino, J. F. (2018) · mSphere · doi:10.1128/msphere.00092-18 · Cited by 296
Fungal infections in animals: a patchwork of different situations
Seyedmousavi, S., Bosco, S. D. M. G., de Hoog, S., Ebel, F., Elad, D., Gomes, R. R., Jacobsen, I. D., Jensen, H. E., Martel, A., Mignon, B. R., et al. (2017) · Medical Mycology · doi:10.1093/mmy/myx104 · Cited by 277
Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia
Schmiedel, Y., & Zimmerli, S. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14281 · Cited by 232
Mechanistic Understanding of Candida albicans Biofilm Formation and Approaches for Its Inhibition
Atriwal, T., Azeem, K., Husain, F. M., Hussain, A., Khan, M. N., Alajmi, M. F., & Abid, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.638609 · Cited by 222
Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species
Czajka, K. M., Venkataraman, K., Brabant-Kirwan, D., Santi, S. A., Verschoor, C. P., Appanna, V. D., Singh, R. I., Saunders, D., & Tharmalingam, S. (2023) · Cells · doi:10.3390/cells12222655 · Cited by 207
Candida Survival Strategies
Polke, M., Hube, B., & Jacobsen, I. D. (2015) · Advances in applied microbiology · doi:10.1016/bs.aambs.2014.12.002 · Cited by 205
Diagnosis and Treatment of Invasive Candidiasis
Barantsevich, N. E., & Barantsevich, E. P. (2022) · Antibiotics · doi:10.3390/antibiotics11060718 · Cited by 209
Fungi of the human gut microbiota: Roles and significance
Pérez, J. C. (2021) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2021.151490 · Cited by 189
Candida albicans and Candida glabrata : global priority pathogens
Katsipoulaki, M., Stappers, M. H. T., Malavia-Jones, D., Brunke, S., Hube, B., & Gow, N. A. R. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00021-23 · Cited by 180
Nosocomial Fungal Infections
Anaissie, E. J., & Bodey, G. P. (1989) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30311-1 · Cited by 159
Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis
Jafri, H., & Ahmad, I. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.100911 · Cited by 163
Selenium nanoparticles from Lactobacillus paracasei HM1 capable of antagonizing animal pathogenic fungi as a new source from human breast milk
El‐Saadony, M. T., Saad, A. M., Taha, T. F., Najjar, A., Zabermawi, N. M., Nader, M. M., AbuQamar, S. F., El-Tarabily, K. A., & Salama, A. A. A. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.07.059 · Cited by 151
Nosocomial Fungal Infections
Suleyman, G., & Alangaden, G. J. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.07.008 · Cited by 141
Candida albicans and Oral Carcinogenesis. A Brief Review
Cosola, M. D., Cazzolla, A. P., Charitos, I. A., Ballini, A., Inchingolo, F., & Santacroce, L. (2021) · Journal of Fungi · doi:10.3390/jof7060476 · Cited by 154
Candida auris: Epidemiology, risk factors, virulence, resistance, and therapeutic options
Sardi, J. D. C. O., Silva, D. R., Mendes‐Giannini, M. J. S., & Rosalen, P. L. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.09.014 · Cited by 138
Candida Auris, An Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind?
Sabino, R., Veríssimo, C., Pereira, Á. A., & Antunes, F. (2020) · Microorganisms · doi:10.3390/microorganisms8020181 · Cited by 133
Epidemiology of hospitalizations associated with invasive candidiasis, United States, 2002-20121
Strollo, S., Lionakis, M. S., Adjemian, J., Steiner, C. A., & Prevots, D. R. (2016) · Emerging Infectious Diseases · doi:10.3201/eid2301.161198 · Cited by 129
Candida glabrata: A Lot More Than Meets the Eye
Kumar, K., Askari, F., Sahu, M. S., & Kaur, R. (2019) · Microorganisms · doi:10.3390/microorganisms7020039 · Cited by 128
Natural Antimicrobial Peptides as Inspiration for Design of a New Generation Antifungal Compounds
Bondaryk, M., Staniszewska, M., Zielińska, P., & Urbańczyk-Lipkowska, Z. (2017) · Journal of Fungi · doi:10.3390/jof3030046 · Cited by 127
Candida albicans Chitin Increases Arginase-1 Activity in Human Macrophages, with an Impact on Macrophage Antimicrobial Functions
Wagener, J., MacCallum, D. M., Brown, G. D., & Gow, N. A. R. (2017) · mBio · doi:10.1128/mbio.01820-16 · Cited by 127
The Role of IL-17 in Protection against Mucosal Candida Infections
Mengesha, B., & Conti, H. R. (2017) · Journal of Fungi · doi:10.3390/jof3040052 · Cited by 127
Green biosynthesis of silver nanoparticles using novel endophytic Rothia endophytica: Characterization and anticandidal activity
Elbahnasawy, M. A., Shehabeldine, A. M., Khattab, A. M., Amin, B. H., & Hashem, A. H. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102401 · Cited by 120
Nosocomial Fungal Infections
Suleyman, G., & Alangaden, G. J. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.08.002 · Cited by 128
Formulation and in vitro evaluation of topical nanosponge-based gel containing butenafine for the treatment of fungal skin infection
Ahmed, M. M., Fatima, F., Anwer, M. K., Ibnouf, E. O., Kalam, M. A., Alshamsan, A., Aldawsari, M. F., Alalaiwe, A. S., & Ansari, M. J. (2021) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2021.04.010 · Cited by 116
Sensitivity of Candida albicans to essential oils: are they an alternative to antifungal agents?
Bona, E., Cantamessa, S., Pavan, M., Novello, G., Massa, N., Rocchetti, A., Berta, G., & Gamalero, E. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13282 · Cited by 124
Nociceptors Boost the Resolution of Fungal Osteoinflammation via the TRP Channel-CGRP-Jdp2 Axis
Maruyama, K., Takayama, Y., Kondo, T., Ishibashi, K.-I., Sahoo, B. R., Kanemaru, H., Kumagai, Y., Martino, M. M., Tanaka, H., Ohno, N., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.002 · Cited by 114
Epidemiology, species distribution, antifungal susceptibility and mortality risk factors of candidemia among critically ill patients: a retrospective study from 2011 to 2017 in a teaching hospital in China
Xiao, Z., Wang, Q., Zhu, F., & An, Y. (2019) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0534-2 · Cited by 111
Molecular Epidemiological Investigation of a Nosocomial Cluster of C. auris: Evidence of Recent Emergence in Italy and Ease of Transmission during the COVID-19 Pandemic
Pilato, V. D., Codda, G., Ball, L., Giacobbe, D. R., Willison, E., Mikulska, M., Magnasco, L., Crea, F., Vena, A., Pelosi, P. P., et al. (2021) · Journal of Fungi · doi:10.3390/jof7020140 · Cited by 109
Investigation of the Antifungal Activity and Mode of Action of Thymus vulgaris, Citrus limonum, Pelargonium graveolens, Cinnamomum cassia, Ocimum basilicum, and Eugenia caryophyllus Essential Oils
Gucwa, K., Milewski, S., Dymerski, T., & Szweda, P. (2018) · Molecules · doi:10.3390/molecules23051116 · Cited by 106
The glyoxylate cycle and alternative carbon metabolism as metabolic adaptation strategies of Candida glabrata: perspectives from Candida albicans and Saccharomyces cerevisiae
Chew, S. Y., Chee, W. J. Y., & Than, L. T. L. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0546-5 · Cited by 111
Sugar Sensing and Signaling in Candida albicans and Candida glabrata
Ende, M. V., Wijnants, S., & Dijck, P. V. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00099 · Cited by 114
Activity of Novel Synthetic Peptides against Candida albicans
Lum, K. Y., Tay, S. T., Le, C. F., Lee, V. S., Sabri, N. H., Velayuthan, R. D., Hassan, H. H., & Sekaran, S. D. (2015) · Scientific Reports · doi:10.1038/srep09657 · Cited by 102
Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unit
Pinhati, H. M. S., Casulari, L. A., Souza, A. C. R., Siqueira, R. A., Damasceno, C. M. G., & Colombo, A. L. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1767-9 · Cited by 102
Efficiency of gold nanoparticles coated with the antimicrobial peptide indolicidin against biofilm formation and development of Candida spp. clinical isolates
de Alteriis, E., Maselli, V., Falanga, A., Galdiero, S., Lella, F. M. D., Gesuele, R., Guida, M., & Galdiero, E. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s164262 · Cited by 99
Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile
Sadeghi, G., Ebrahimi-Rad, M., Mousavi, S. F., Shams-Ghahfarokhi, M., & Razzaghi-Abyaneh, M. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2017.12.008 · Cited by 96
Extracellular proteinases of Candida species pathogenic yeasts
Rapala‐Kozik, M., Bochenska, O., Zajac, D., Karkowska‐Kuleta, J., Gogol, M., Zawrotniak, M., & Kozik, A. (2018) · Molecular Oral Microbiology · doi:10.1111/omi.12206 · Cited by 94
Strategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries
Kaur, H., & Chakrabarti, A. (2017) · Journal of Fungi · doi:10.3390/jof3030041 · Cited by 93
Fungi as Part of the Microbiota and Interactions with Intestinal Bacteria
Kapitan, M., Niemiec, M. J., Steimle, A., Frick, J.-S., & Jacobsen, I. D. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_117 · Cited by 101
Increasing candidaemia incidence from 2004 to 2015 with a shift in epidemiology in patients preexposed to antifungals
Goemaere, B., Becker, P., Wijngaerden, E. V., Maertens, J. A., Spriet, I., Hendrickx, M., & Lagrou, K. (2017) · Mycoses · doi:10.1111/myc.12714 · Cited by 92
Farnesol signalling in Candida albicans – more than just communication
Polke, M., Leonhardt, I., Kurzai, O., & Jacobsen, I. D. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2017.1337711 · Cited by 92
Antifungal innate immunity: recognition and inflammatory networks
Becker, K. L., Ifrim, D. C., Quintin, J., Netea, M. G., & van de Veerdonk, F. L. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-014-0467-z · Cited by 86
Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing
Spettel, K., Barousch, W., Makristathis, A., Zeller, I., Nehr, M., Selitsch, B., Lackner, M., Rath, P.-M., Steinmann, J., & Willinger, B. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210397 · Cited by 86
UPLC-MS/MS method for the simultaneous determination of imatinib, voriconazole and their metabolites concentrations in rat plasma
Xu, R.-A., Lin, Q., Qiu, X., Chen, J., Shao, Y., Hu, G., & Lin, G. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.12.036 · Cited by 85
Antibiofilm Activities of Biogenic Silver Nanoparticles Against Candida albicans
Ahamad, I., Bano, F., Anwer, R., Srivastava, P., Kumar, R., & Fatma, T. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.741493 · Cited by 86
Epidemiology and antifungal susceptibility of Candida species in a tertiary care hospital, Kolkata, India
Bhattacharjee, P. (2016) · Current Medical Mycology · doi:10.18869/acadpub.cmm.2.2.5 · Cited by 93
Antimicrobial and antibiofilm activities of nanoemulsions containing Eucalyptus globulus oil against Pseudomonas aeruginosa and Candida spp.
Quatrin, P. M., Verdi, C. M., de Souza, M. E., de Godoi, S. N., Klein, B., Gündel, A., Wagner, R. C., Vaucher, R. D. A., Ourique, A. F., & Santos, R. C. V. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.09.062 · Cited by 86
Distribution of Candida albicans and non-albicans Candida species isolated in different clinical samples and their in vitro antifungal suscetibity profile in Ethiopia
Seyoum, E., Bitew, A., & Mihret, A. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-4883-5 · Cited by 87
Silver Nanoparticles Addition in Poly(Methyl Methacrylate) Dental Matrix: Topographic and Antimycotic Studies
Matteis, V. D., Cascione, M., Toma, C. C., Albanese, G., Giorgi, M. L. D., Corsalini, M., & Rinaldi, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194691 · Cited by 80
Consensus guidelines for the treatment of yeast infections in the haematology, oncology and intensive care setting, 2014
Chen, S. C., Sorrell, T. C., Chang, C. C., Paige, E. K., Bryant, P. A., & Slavin, M. A. (2014) · Internal Medicine Journal · doi:10.1111/imj.12597 · Cited by 81
Amphotericin B-conjugated biogenic silver nanoparticles as an innovative strategy for fungal infections
Ahmad, A., Wei, Y., Syed, F., Tahir, K., Taj, R., Khan, A. U., Hameed, M. U., & Yuan, Q. (2016) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.08.031 · Cited by 81
Current advances of triazole alcohols derived from fluconazole: Design, in vitro and in silico studies
Emami, S., Ghobadi, E., Saednia, S., & Hashemi, S. M. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.03.020 · Cited by 81
COVID-19-Associated Candidiasis: Possible Patho-Mechanism, Predisposing Factors, and Prevention Strategies
Ahmed, N., Mahmood, M. S., Ullah, M. A., Araf, Y., Rahaman, T. I., Moin, A. T., & Hosen, M. J. (2022) · Current Microbiology · doi:10.1007/s00284-022-02824-6 · Cited by 79
Function and subcellular localization of Gcn5, a histone acetyltransferase in Candida albicans.
Chang, P., Fan, X., & Chen, J. (2015) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2015.01.011 · Cited by 73
Bioinspired Zinc Oxide Nanoparticles Using Lycopersicon esculentum for Antimicrobial and Anticancer Applications
Vijayakumar, S., Vaseeharan, B., Sudhakaran, R., Jeyakandan, J., Ramasamy, P., Sonawane, A., Padhi, A., Velusamy, P., Anbu, P., & Faggio, C. (2019) · Journal of Cluster Science · doi:10.1007/s10876-019-01590-z · Cited by 72
Application of machine learning-assisted surface-enhanced Raman spectroscopy in medical laboratories: Principles, opportunities, and challenges
Tang, J., Yuan, Q., Zhang, L., Marshall, B. J., Tay, C. Y., & Wang, L. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118135 · Cited by 71
Candidemia in children: Epidemiology, prevention and management
Mantadakis, E., Pana, Z. D., & Zaoutis, T. E. (2018) · Mycoses · doi:10.1111/myc.12792 · Cited by 73
Amelioration of ketoconazole in lipid nanoparticles for enhanced antifungal activity and bioavailability through oral administration for management of fungal infections
Dudhipala, N. R., & Youssef, A. A. A. (2020) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2020.104953 · Cited by 69
Prevalence, virulence factors and antifungal susceptibility ofCandidaspp. isolated from bloodstream infections in a tertiary care hospital in Brazil
Canela, H. M. S., Cardoso, B., Vitali, L. H., Coêlho, H. C., Martínez, R., & Ferreira, M. E. D. S. (2017) · Mycoses · doi:10.1111/myc.12695 · Cited by 69
Epidemiology and prognostic factors of nosocomial candidemia in Northeast Brazil: A six-year retrospective study
de Medeiros, M. A. P., de Melo, A. P. V., Bento, A. D. O., de Souza, L. B. F. C., Neto, F. D. A. B., Garcia, J. B.-L., Zuza-Alves, D. L., Francisco, E. C., Melo, A. S. D. A., & Chaves, G. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221033 · Cited by 68
Rapid proliferation due to better metabolic adaptation results in full virulence of a filament-deficient Candida albicans strain
Dunker, C., Polke, M., Schulze, B., Schubert, K., Rudolphi, S., Gressler, A. E., Pawlik, T., Prada, J. P., Niemiec, M. J., Slesiona, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24095-8 · Cited by 71
Candida auris: a comparison between planktonic and biofilm susceptibility to antifungal drugs
Romera, D., Aguilera-Correa, J. J., Gadea, I., Viñuela-Sandoval, L., García‐Rodríguez, J., & Esteban, J. (2019) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001036 · Cited by 69
Silibinin triggers yeast apoptosis related to mitochondrial Ca2+ influx in Candida albicans
Yun, D. G., & Lee, D. G. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.09.008 · Cited by 67
Silymarin exerts antifungal effects via membrane-targeted mode of action by increasing permeability and inducing oxidative stress
Yun, D. G., & Lee, D. G. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.01.009 · Cited by 67
Retrospective analysis of mortality and Candida isolates of 75 patients with candidemia: a single hospital experience
Hirano, R., Sakamoto, Y., Kudo, K., & Ohnishi, M. (2015) · Infection and Drug Resistance · doi:10.2147/idr.s80677 · Cited by 65
Linking Cellular Morphogenesis with Antifungal Treatment and Susceptibility in Candida Pathogens
Sharma, J., Rosiana, S., Razzaq, I., & Shapiro, R. S. (2019) · Journal of Fungi · doi:10.3390/jof5010017 · Cited by 69
Medically Important Fungi Respond to Azole Drugs: An Update
Zavřel, M., & White, T. C. (2015) · Future Microbiology · doi:10.2217/fmb.15.47 · Cited by 64
Remasking of Candida albicans β-Glucan in Response to Environmental pH Is Regulated by Quorum Sensing
Cottier, F., Sherrington, S. L., Cockerill, S., del Olmo, V., Kissane, S., Tournu, H., Orsini, L., Palmer, G. E., Pérez, J. C., & Hall, R. A. (2019) · mBio · doi:10.1128/mbio.02347-19 · Cited by 62
Effectiveness of Phytoactive Molecules on Transcriptional Expression, Biofilm Matrix, and Cell Wall Components of Candida glabrata and Its Clinical Isolates
Gupta, P., Gupta, S., Sharma, M., Kumar, N., Pruthi, V., & Poluri, K. M. (2018) · ACS Omega · doi:10.1021/acsomega.8b01856 · Cited by 66
Chilean crab (Aegla cholchol) as a new source of chitin and chitosan with antifungal properties against Candida spp
Bernabé, P., Becherán, L., Cabrera‐Barjas, G., Nešić, A., Claudio Alburquenque, O., Tapia, C. V., Taboada, E., Alderete, J. B., & Ríos-Escalante, P. D. L. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.01.126 · Cited by 63
Risk Factors of Candida parapsilosis Catheter-Related Bloodstream Infection
Yamin, D., Husin, A., & Harun, A. B. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.631865 · Cited by 65
Infrared Spectroscopy of Blood
Kochan, K., Bedolla, D. E., Pérez-Guaita, D., Adegoke, J. A., Veettil, T. C. P., Martin, M., Roy, S., Pebotuwa, S., Heraud, P., & Wood, B. R. (2020) · Applied Spectroscopy · doi:10.1177/0003702820985856 · Cited by 63
Characteristics and Management of Candidaemia Episodes in an Established Candida auris Outbreak
Bayona, J. V. M., Tormo, N., García, C. S., Rodríguez, P. H., de Medrano, V. A. L., Gómez, C. F., & Cardona, C. G. (2020) · Antibiotics · doi:10.3390/antibiotics9090558 · Cited by 62
Potential Synergistic Action of Bioactive Compounds from Plant Extracts against Skin Infecting Microorganisms
Sitarek, P., Merecz-Sadowska, A., Kowalczyk, T., Wieczfińska, J., Zajdel, R., & Śliwiński, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145105 · Cited by 71
The Role of Dectin-2 for Host Defense Against Disseminated Candidiasis
Ifrim, D. C., Quintin, J., Courjol, F., Verschueren, I., van Krieken, J. H., Köentgen, F., Fradin, C., Gow, N. A. R., Joosten, L. A. B., van der Meer, J. W. M., et al. (2016) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2015.0040 · Cited by 64
Propolis: A Potential Natural Product to Fight Candida Species Infections
Tobaldini-Valério, F. K., Mendonca, P., Rosseto, H. C., Bruschi, M. L., Henriques, M., Negri, M., Silva, S. M., & Svidzinski, T. I. E. (2016) · Future Microbiology · doi:10.2217/fmb-2015-0016 · Cited by 65
The Fungal Histone Acetyl Transferase Gcn5 Controls Virulence of the Human Pathogen Candida albicans through Multiple Pathways
Shivarathri, R., Tscherner, M., Zwolanek, F., Singh, N. K., Chauhan, N., & Kuchler, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-45817-5 · Cited by 58
In silico Design of a Multivalent Vaccine Against Candida albicans
Tarang, S., Kesherwani, V., LaTendresse, B., Lindgren, L., Rocha-Sanchez, S. M., & Weston, M. D. (2020) · Scientific Reports · doi:10.1038/s41598-020-57906-x · Cited by 58
Risk of invasive candidiasis with prolonged duration of ICU stay: a systematic review and meta-analysis
Zhang, Z., Zhu, R., Luan, Z., & Ma, X. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-036452 · Cited by 59
Fungal Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patients
Bays, D. J., & Thompson, G. R. (2019) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2019.02.006 · Cited by 56
The role of pattern recognition receptors in the innate recognition of Candida albicans
Zheng, N.-X., Wang, Y., Hu, D.-D., Yan, L., & Jiang, Y.-Y. (2015) · Virulence · doi:10.1080/21505594.2015.1014270 · Cited by 52
Species distribution and in vitro antifungal susceptibility profiles of yeast isolates from invasive infections during a Portuguese multicenter survey
Faria‐Ramos, I., Neves-Maia, J., Ricardo, E., Santos‐Antunes, J., Silva, A. P., Costa‐de‐Oliveira, S., Cantón, R., Rodrigues, A. G., & Pina‐Vaz, C. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2194-8 · Cited by 55
Attributable mortality of candidemia after introduction of echinocandins
Cornely, F. B., Cornely, O. A., Salmanton‐García, J., Koehler, F. C., Koehler, P. A., Seifert, H., Wingen-Heimann, S. M., & Mellinghoff, S. C. (2020) · Mycoses · doi:10.1111/myc.13177 · Cited by 56
Antibiofilm Activity on Candida albicans and Mechanism of Action on Biomembrane Models of the Antimicrobial Peptide Ctn[15–34]
de Aguiar, F. L. L., Santos, N. C., Cavalcante, C. S. D. P., Andreu, D., Rádis‐Baptista, G., & Gonçalves, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218339 · Cited by 54
Silver nanoparticle stabilized by hydrolyzed collagen and natural polymers: Synthesis, characterization and antibacterial-antifungal evaluation
Nogueira, S. S., de Araújo, A. R., Mafud, A. C., Guimarães, M. A., Alves, M. M. D. M., Plácido, A., Carvalho, F. A. D. A., Arcanjo, D. D. R., Mascarenhas, Y. P., Costa, F. G., et al. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.05.214 · Cited by 55
An Atlas of Genetic Variation Linking Pathogen-Induced Cellular Traits to Human Disease
Wang, L., Pittman, K. J., Barker, J. R., Salinas, R., Stanaway, I. B., Williams, G. D., Carroll, R. J., Balmat, T., Ingham, A., Gopalakrishnan, A. M., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.07.007 · Cited by 55
Mode of action and anti-Candida activity of Artemisia annua mediated-synthesized silver nanoparticles
Khatoon, N., Sharma, Y., Sardar, M., & Manzoor, N. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.07.005 · Cited by 56
The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor—Active Surveillance in Selected Sites, United States, 2014–2017
Zhang, A. Y., Shrum, S., Williams, S., Petnic, S., Nadle, J., Johnston, H., Barter, D., Vonbank, B., Bonner, L., Hollick, R., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1061 · Cited by 54
Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey
Dağı, H. T., Fındık, D., Senkeles, C., & Arslan, U. (2016) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-016-0153-1 · Cited by 57
Molecular Epidemiology and Antifungal Susceptibility of Candida glabrata in China (August 2009 to July 2014): A Multi-Center Study
Hou, X., Xiao, M., Chen, S. C.-A., Kong, F., Wang, H., Chu, Y., Kang, M., Sun, Z., Hu, Z., Li, R., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00880 · Cited by 55
The changing spectrum of Saccharomycotina yeasts causing candidemia: phylogeny mirrors antifungal susceptibility patterns for azole drugs and amphothericin B
Stavrou, A. A., Lackner, M., Lass‐Flörl, C., & Boekhout, T. (2019) · FEMS Yeast Research · doi:10.1093/femsyr/foz037 · Cited by 53
The in vivo anti-Candida albicans activity of flavonoids
Nguyen, W., Grigori, L., Just, E., Santos, C., & Seleem, D. (2021) · Journal of Oral Biosciences · doi:10.1016/j.job.2021.03.004 · Cited by 54

Authors: Yapar, N.
Affiliations: Dokuz Eylül University (TR)
Corresponding author: Yapar, Nur
ORCID: Yapar, Nur
Venue: Therapeutics and Clinical Risk Management
Publisher: Informa UK Limited
Published: 2014-02
Volume: 10
Pages: 95
ISSN: 1176-6336 (ISSN-L)
1178-203X
DOI: 10.2147/tcrm.s40160
PMC: PMC3928396
OpenAlex: W2149946566
Cited by: 610
References: 70
Citations by year: 2026: 13 · 2025: 29 · 2024: 42 · 2023: 39 · 2022: 48 · 2021: 69 · 2020: 93 · 2019: 74 · 2018: 60 · 2017: 54 · 2016: 44 · 2015: 32 · 2014: 11
FWCI: 6.53
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by-nc
creativecommons.org/licenses/by-nc/3.0/ (vor)
Locations: Therapeutics and Clinical Risk Management (publishedVersion, cc-by-nc)
Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
PubMed Central (publishedVersion, cc-by-nc)
PubMed (publishedVersion)
Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
Keywords: invasive candidiasis, Candida albicans, non-albicans Candida, immunosuppression, opportunistic fungal infection, risk factors, epidemiology, antifungal prophylaxis, secondary prophylaxis, preemptive antifungal therapy, species distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Epidemiology and risk factors for invasive candidiasis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks